PATENT CLAIM ANALYSIS

Application Number: 15771775
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-12
Patent Classification: ["540", "575000"]

Abstract:
The present invention relates to a compound represented by Chemical Formula, or a pharmaceutically acceptable salt thereof. The compound according to the present invention can be usefully used for the prevention or treatment of sodium channel blocker-related diseases.

Claim (Index 13):
The pharmaceutical composition according to  claim 12 , wherein the sodium channel blocker-related diseases are acute pain, chronic pain, neuropathic pain, postoperative pain, migraine, arthralgia, neuropathy, nerve damage, diabetic neuropathy, neuropathic disease, epilepsy, arrhythmia, myotonia, ataxia, multiple sclerosis, irritable bowel syndrome, urinary incontinence, visceral pain, depression, erythralgia, or PEPD (paroxysmal extreme pain disorder).

Metadata:
- Claim Count in Document: 1.0
- Percentile: 91.0
- Lexical Diversity: 1.28125
- Patent Class: 540.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['16061815', '16086654', '14435473', '13707096', '11728897']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7237838054213055
- 35 USC 102 Novelty (BERT): 0.5761299708337799
- Combined Prediction Score: 0.7090184219625529
- Mean Citation Score: 414.399758
- Max Citation Score: 452.23602
- Similarity Product: 388.4647424247337

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test